Sun Life Financial gets moderate‑buy consensus, Sight Sciences holds rating

Sun Life Financial Inc. received a consensus recommendation of "Moderate Buy" from twelve brokerage analysts covering the stock. The consensus is based on one sell, five holds, five buys and one strong‑buy rating, with an average 12‑month price target of $84.67. Recent analyst actions include Weiss Ratings reiterating a buy rating, Argus setting an $81 target, Canadian Imperial Bank of Commerce maintaining a neutral stance, TD Cowen issuing a buy, and Evercore downgrading the rating from outperform to in‑line. Institutional investors added to their holdings, with Norges Bank acquiring a $398 million stake and Morgan Stanley increasing its position to $246 million, among others.

Sight Sciences, Inc. earned a consensus "Hold" rating from nine analysts. The breakdown is one sell, three holds and five buys, with an average 12‑month price target of $7.75. Recent analyst reports include UBS starting coverage with a buy rating and a $7 target, and Citigroup raising its price objective to $6 while assigning a neutral rating. Weiss Ratings lowered its rating from sell‑D to sell‑E+. Insider activity featured CFO James Rodberg selling 6,902 shares and insider Jeremy B. Hayden selling 12,733 shares, contributing to 58,566 shares sold by insiders over the past 90 days. Institutional activity saw Americana Partners increasing its stake by 12.1% to a $10.9 million holding.